Common Stock, Shares, Outstanding of VERTEX PHARMACEUTICALS INC / MA from Q1 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
VERTEX PHARMACEUTICALS INC / MA quarterly Common Stock, Shares, Outstanding history and change rate from Q1 2010 to Q3 2025.
  • VERTEX PHARMACEUTICALS INC / MA Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 253,951,475, a 1.5% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

VERTEX PHARMACEUTICALS INC / MA Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 253,951,475 -3,788,124 -1.5% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 256,293,058 -1,722,243 -0.67% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 256,967,767 -1,328,482 -0.51% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 256,940,382 -754,839 -0.29% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 257,739,599 -88,909 -0.03% 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 258,015,301 +222,653 +0.09% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 258,296,249 +786,488 +0.3% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 257,695,221 +683,593 +0.27% 31 Dec 2023 10-K 13 Feb 2025 2024 FY
Q3 2023 257,828,508 +1,182,771 +0.46% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 257,792,648 +1,766,447 +0.69% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 257,509,761 +1,934,800 +0.76% 31 Mar 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 257,011,628 +2,532,582 +1% 31 Dec 2022 10-K 15 Feb 2024 2023 FY
Q3 2022 256,645,737 +439,737 +0.17% 30 Sep 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 256,026,201 -3,087,799 -1.2% 30 Jun 2022 10-Q 05 Aug 2022 2022 Q2
Q1 2022 255,574,961 -3,254,039 -1.3% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 254,479,046 -5,410,503 -2.1% 31 Dec 2021 10-K 10 Feb 2023 2022 FY
Q3 2021 256,206,000 -3,968,000 -1.5% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 259,114,000 -1,010,000 -0.39% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 258,829,000 -250,000 -0.1% 31 Mar 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 259,889,549 +896,549 +0.35% 31 Dec 2020 10-K 09 Feb 2022 2021 FY
Q3 2020 260,174,000 +2,909,000 +1.1% 30 Sep 2020 10-Q 30 Oct 2020 2020 Q3
Q2 2020 260,124,000 +3,453,000 +1.3% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 259,079,000 +2,728,000 +1.1% 31 Mar 2020 10-Q 01 May 2020 2020 Q1
Q4 2019 258,993,000 +3,821,000 +1.5% 31 Dec 2019 10-K 11 Feb 2021 2020 FY
Q3 2019 257,265,000 +1,654,188 +0.65% 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 256,671,000 +1,788,163 +0.7% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 256,351,000 +1,483,135 +0.58% 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 255,172,000 +1,918,638 +0.76% 31 Dec 2018 10-K 13 Feb 2020 2019 FY
Q3 2018 255,610,812 +2,927,466 +1.2% 30 Sep 2018 10-Q 25 Oct 2018 2018 Q3
Q2 2018 254,882,837 +4,112,931 +1.6% 30 Jun 2018 10-Q 26 Jul 2018 2018 Q2
Q1 2018 254,867,865 +5,977,031 +2.4% 31 Mar 2018 10-Q 27 Apr 2018 2018 Q1
Q4 2017 253,253,362 +4,952,845 +2% 31 Dec 2017 10-K 13 Feb 2019 2018 FY
Q3 2017 252,683,346 +4,654,384 +1.9% 30 Sep 2017 10-Q 30 Oct 2017 2017 Q3
Q2 2017 250,769,906 +3,065,974 +1.2% 30 Jun 2017 10-Q 28 Jul 2017 2017 Q2
Q1 2017 248,890,834 +1,604,129 +0.65% 31 Mar 2017 10-Q 28 Apr 2017 2017 Q1
Q4 2016 248,300,517 +1,993,699 +0.81% 31 Dec 2016 10-K 15 Feb 2018 2017 FY
Q3 2016 248,028,962 +2,382,693 +0.97% 30 Sep 2016 10-Q 31 Oct 2016 2016 Q3
Q2 2016 247,703,932 +3,362,231 +1.4% 30 Jun 2016 10-Q 01 Aug 2016 2016 Q2
Q1 2016 247,286,705 +3,706,673 +1.5% 31 Mar 2016 10-Q 03 May 2016 2016 Q1
Q4 2015 246,306,818 +4,542,420 +1.9% 31 Dec 2015 10-K 23 Feb 2017 2016 FY
Q3 2015 245,646,269 +5,408,179 +2.3% 30 Sep 2015 10-Q 30 Oct 2015 2015 Q3
Q2 2015 244,341,701 +7,010,615 +3% 30 Jun 2015 10-Q 04 Aug 2015 2015 Q2
Q1 2015 243,580,032 +7,378,699 +3.1% 31 Mar 2015 10-Q 04 May 2015 2015 Q1
Q4 2014 241,764,398 +7,975,546 +3.4% 31 Dec 2014 10-K 16 Feb 2016 2015 FY
Q3 2014 240,238,090 +6,645,889 +2.8% 30 Sep 2014 10-Q 06 Nov 2014 2014 Q3
Q2 2014 237,331,086 30 Jun 2014 10-Q 31 Jul 2014 2014 Q2
Q1 2014 236,201,333 +17,549,629 +8% 31 Mar 2014 10-Q 05 May 2014 2014 Q1
Q4 2013 233,788,852 +16,501,984 +7.6% 31 Dec 2013 10-K 13 Feb 2015 2014 FY
Q3 2013 233,592,201 +17,250,696 +8% 30 Sep 2013 10-Q 07 Nov 2013 2013 Q3
Q1 2013 218,651,704 +7,788,351 +3.7% 31 Mar 2013 10-Q 08 May 2013 2013 Q1
Q4 2012 217,286,868 +7,982,873 +3.8% 31 Dec 2012 10-K 11 Feb 2014 2013 FY
Q3 2012 216,341,505 +7,880,727 +3.8% 30 Sep 2012 10-Q 06 Nov 2012 2012 Q3
Q2 2012 215,434,666 +7,961,473 +3.8% 30 Jun 2012 10-Q 08 Aug 2012 2012 Q2
Q1 2012 210,863,353 +5,405,347 +2.6% 31 Mar 2012 10-Q 10 May 2012 2012 Q1
Q4 2011 209,303,995 +5,781,019 +2.8% 31 Dec 2011 10-K 01 Mar 2013 2012 FY
Q3 2011 208,460,778 +5,360,246 +2.6% 30 Sep 2011 10-Q 03 Nov 2011 2011 Q3
Q2 2011 207,473,193 +4,940,268 +2.4% 30 Jun 2011 10-Q 09 Aug 2011 2011 Q2
Q1 2011 205,458,006 +3,335,209 +1.6% 31 Mar 2011 10-Q 06 May 2011 2011 Q1
Q4 2010 203,522,976 31 Dec 2010 10-K 22 Feb 2012 2011 FY
Q3 2010 203,100,532 30 Sep 2010 10-Q 28 Oct 2010 2010 Q3
Q2 2010 202,532,925 30 Jun 2010 10-Q 03 Aug 2010 2010 Q2
Q1 2010 202,122,797 31 Mar 2010 10-Q 03 May 2010 2010 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.